a public good project by the
Synthesis
Company
of California

© 2026

Martin Gore | doi.page

0 works0 citations0 h-index

Martin Gore

Imperial College London(GB)

Publications by Year

Research Areas

Ovarian cancer diagnosis and treatment, Renal cell carcinoma treatment, Melanoma and MAPK Pathways, Cancer Genomics and Diagnostics, Cutaneous Melanoma Detection and Management

Most-Cited Works

→ Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing(2012)7,705 cited
→ Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma(2007)4,772 cited
→ Carboplatin dosage: prospective evaluation of a simple formula based on renal function.(1989)1,880 cited
→ Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial(2011)1,839 cited
→ Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma(2000)1,264 cited
→ Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing(2014)1,246 cited

→ Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma(2018)

1,227 cited

→ Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan(2001)1,223 cited

→ A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer(2000)1,100 cited

→ Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial(2009)1,079 cited